Calendar

pharmadog

Week of Dec 8, 2025

Dec 12, 2025approval261d agoADBRY (TRALOKINUMAB) — FDA approvaltralokinumab

Sponsor: LEO PHARMA AS. Form: INJECTABLE. Route: INJECTION

full page →tralokinumab →fda approvals ↗

Dec 12, 2025approval261d agoROMVIMZA (VIMSELTINIB) — FDA approvalDeciphera Pharmaceuticals Inc

Sponsor: DECIPHERA PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Dec 12, 2025approval261d agoSTEQEYMA (USTEKINUMAB-STBA) — FDA approvalSTEQEYMA

Sponsor: CELLTRION, INC.. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →STEQEYMA →fda approvals ↗

Dec 12, 2025approval261d agoNUZOLVENCE (ZOLIFLODACIN) — FDA approvalEntasis Therapeutics Holdings Inc

Sponsor: ENTASIS THERAP. Form: FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Dec 12, 2025approval261d agoOCTREOTIDE ACETATE — FDA approvalChiasma Inc

Sponsor: MYLAN LABS LTD. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Dec 12, 2025approval261d agoTERIPARATIDE — FDA approvalEB-613

Sponsor: AMPHASTAR PHARMS INC. Form: SOLUTION. Route: SUBCUTANEOUS

full page →EB-613 →fda approvals ↗

Dec 12, 2025approval261d agoNISOLDIPINE — FDA approvalPrasco LLC

Sponsor: AMTA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Dec 12, 2025approval261d agoLEROCHOL (LERODALCIBEP-LIGA) — FDA approvallerodalcibep

Sponsor: LIB THERAPEUTICS, INC.. Form: INJECTABLE. Route: INJECTION

full page →lerodalcibep →fda approvals ↗

Dec 12, 2025approval261d agoDEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalmedroxyprogesterone acetate

Sponsor: PFIZER. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →medroxyprogesterone acetate →fda approvals ↗

Dec 12, 2025approval261d agoILUMYA (TILDRAKIZUMAB-ASMN) — FDA approvalSun Pharmaceutical Industries Ltd

Sponsor: SUN PHARMA GLOBAL. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Dec 12, 2025approval261d agoDEFLAZACORT — FDA approvalDEFLAZACORT

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →DEFLAZACORT →fda approvals ↗

Dec 12, 2025approval261d agoCARDAMYST (ETRIPAMIL) — FDA approvalMilestone Pharmaceuticals Inc.

Sponsor: MILESTONE PHARMS USA. Form: SPRAY. Route: NASAL

full page →fda approvals ↗

Dec 12, 2025approval261d agoDEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approvalmedroxyprogesterone acetate

Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

full page →medroxyprogesterone acetate →fda approvals ↗

Dec 12, 2025approval261d agoAKEEGA (ABIRATERONE ACETATE) — FDA approval(abiraterone acetate + niraparib)

Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL

full page →(abiraterone acetate + niraparib) →fda approvals ↗

Dec 12, 2025approval261d agoROLVEDON (EFLAPEGRASTIM-XNST) — FDA approvalSpectrum Pharmaceuticals Inc

Sponsor: SPECTRUM PHARMS. Form: INJECTABLE. Route: SUBCUTANEOUS

full page →fda approvals ↗

Dec 13, 2025approval260d agoADDYI (FLIBANSERIN) — FDA approvalSprout2 Inc

Sponsor: SPROUT PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Dec 14, 2025approval259d agoHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalacetaminophen ER

Sponsor: WES PHARMA INC. Form: TABLET. Route: ORAL

full page →acetaminophen ER →fda approvals ↗

Week of Dec 15, 2025

Dec 15, 2025approval258d agoLEQEMBI (LECANEMAB-IRMB) — FDA approvallecanemab

Sponsor: EISAI INC. Form: INJECTABLE. Route: INJECTION

full page →lecanemab →fda approvals ↗

Dec 15, 2025approval

← prev

page 347 of 392

Week of Dec 8, 2025

Week of Dec 15, 2025